APT Medical Inc.
688617
株式のランク
#3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
株価
$38.62
時価総額
$5.47B
変化（1日）
0.19%
変化（1年）
-17.07%
国
CN
取引 APT Medical Inc. (688617)
カテゴリー
Healthcare
APT Medical Inc.（688617）の発行済株式数
June 2026 時点の発行済株式数 139.23M
APT Medical Inc. の最新の財務報告および株価によると、現在の発行済株式数は 139.23M です。December 2024 の終わりには、同社は 141.05M 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
APT Medical Inc.（688617）の発行済株式数の履歴（2017 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 139.23M | -1.26% |
| 2025 | 141.00M | -0.03% |
| 2024 | 141.05M | -0.52% |
| 2023 | 141.79M | -0.16% |
| 2022 | 142.03M | 2.99% |
| 2021 | 137.91M | 31.45% |
| 2020 | 104.91M | -0.29% |
| 2019 | 105.22M | 0.09% |
| 2018 | 105.13M | 0.00% |
| 2017 | 105.13M | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 1.74B | 1,148.42% |
US
|
|
| 1.28B | 819.22% |
IE
|
|
| 383.50M | 175.45% |
US
|
|
| 1.48B | 961.29% |
US
|
|
| 1.12B | 703.86% |
DE
|
